Status:
COMPLETED
Twentyfour Ambulatory Pulse Wave Velocity and Central Augmentation Index in Type 2 Diabetes
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Regionshospitalet Silkeborg
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
30-75 years
Brief Summary
The functionality and reproducibility of pulse wave analysis is investigated in 20 type 2 diabetic patients who had two 24 hour measurements performed within one week with the Arteriograph24 equipment...
Detailed Description
Arteriograph24 is a new monitor for measuring ambulatory blood pressure and additional performing brachial cuff based on analysis of a suprasystolic pulse wave. The study aim to test the feasibility ...
Eligibility Criteria
Inclusion
- Type 2 diabetes
Exclusion
- Atrial fibrillation
Key Trial Info
Start Date :
September 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01812811
Start Date
September 1 2012
End Date
July 1 2013
Last Update
December 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical department, Diagnostic Center, Regional Hospital Silkeborg
Silkeborg, Silkeborg, Denmark, 8600